Evidence map›Paper›PMID 27525637›Full record

ArticleJournal of molecular neuroscience : MN2016

Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus.

Olympia Gianfrancesco, Daniel Griffiths, Paul Myers, David A Collier, Vivien J Bubb, John P Quinn

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular neuroscience : MN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Non-coding genetic variation shaping mental health.Current opinion in psychology · 2019
    Review
  2. Review
  3. A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Olympia GianfrancescoDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, L69 3BX, Liverpool, UK.ORCID http://orcid.org/0000-0002-1613-5247
Daniel GriffithsDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, L69 3BX, Liverpool, UK.
Paul MyersDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, L69 3BX, Liverpool, UK.
David A CollierEli Lilly and Company Limited, Windlesham, Surrey, UK.
Vivien J BubbDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, L69 3BX, Liverpool, UK.
John P QuinnDepartment of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, L69 3BX, Liverpool, UK. jquinn@liverpool.ac.uk.
University of Liverpool · GBEli Lilly (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have identified a region at chromosome 1p21.3, containing the microRNA MIR137, to be among the most significant associations for schizophrenia. However, the mechanism by which genetic variation at this locus increases risk of schizophrenia is unknown. Identifying key regulatory regions around MIR137 is crucial to understanding the potential role of this gene in the aetiology of psychiatric disorders. Through alignment of vertebrate genomes, we identified seven non-coding regions at the MIR137 locus with conservation comparable to exons (>70 %). Bioinformatic analysis using the Psychiatric Genomics Consortium GWAS dataset for schizophrenia showed five of the ECRs to have genome-wide significant SNPs in or adjacent to their sequence. Analysis of available datasets on chromatin marks and histone modification data showed that three of the ECRs were predicted to be functional in the human brain, and three in development. In vitro analysis of ECR activity using reporter gene assays showed that all seven of the selected ECRs displayed transcriptional regulatory activity in the SH-SY5Y neuroblastoma cell line. This data suggests a regulatory role in the developing and adult brain for these highly conserved regions at the MIR137 schizophrenia-associated locus and further that these domains could act individually or synergistically to regulate levels of MIR137 expression.

Indexed as

Conserved SequenceGenetic LociRegulatory Sequences, Nucleic AcidCell Line, TumorEvolution, MolecularHistonesHumansMicroRNAsPolymorphism, Single NucleotideProtein Processing, Post-TranslationalSchizophreniaHistonesMicroRNAsMIRN137 microRNA, humanGene expressionGene regulationGeneticsmicroRNA-137SchizophreniaTranscription

Identifiers

PMID27525637
PMCPMC5026716
OpenAlexW2509432097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.